Cite
Neurotoxicity with high-dose disulfiram and vorinostat used for HIV latency reversal
MLA
McMahon, J. H., et al. “Neurotoxicity with High-Dose Disulfiram and Vorinostat Used for HIV Latency Reversal.” Aids, 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1313515389&authtype=sso&custid=ns315887.
APA
McMahon, J. H., Evans, V. A., Lau, J. S., Symons, J., Zerbato, J. M., Chang, J., Solomon, A., Tennakoon, S., Dantanarayana, A., Hagenauer, M., Lee, S., Palmer, S., Fisher, K., Bumpus, N., Heck, C. J. S., Burger, D. M., Wu, G., Zuck, P., Howell, B. J., … Lewin, S. R. (2022). Neurotoxicity with high-dose disulfiram and vorinostat used for HIV latency reversal. Aids.
Chicago
McMahon, J.H., V.A. Evans, J.S. Lau, J. Symons, J.M. Zerbato, J. Chang, A. Solomon, et al. 2022. “Neurotoxicity with High-Dose Disulfiram and Vorinostat Used for HIV Latency Reversal.” Aids. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1313515389&authtype=sso&custid=ns315887.